Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease: An Analysis of Systematic Reviews

Annals of Pharmacotherapy

Volumn 47, Issue 11, 2013, Pages 1498-1506

  Salgado, Teresa M ^a   Correr, Cassyano J ^b   Moles, Rebekah ^c   Benrimoj, Shalom I ^d   Fernandez Llimos, Fernando ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

chronic kidney disease; clinical pharmacy services; evidence based practice; pharmacist interventions

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM PHOSPHATE; CHOLESTEROL; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL; VITAMIN D DERIVATIVE;

ANEMIA; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL PHARMACY; COST CONTROL; DISEASE SEVERITY; DRUG INFORMATION; EVIDENCE BASED PRACTICE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; LABORATORY TEST; MEDICAL RECORD; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT TRANSPORT; PHARMACIST; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

CHRONIC KIDNEY DISEASE; CLINICAL PHARMACY SERVICES; EVIDENCE-BASED PRACTICE; PHARMACIST INTERVENTIONS;

HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84889034304     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013501802     Document Type: Review

References (74)

1. Chisholm-Burns MA,Kim Lee J,Spivey CA,et al.US pharmacists' effect as team members on patient care: systematic review and meta-analyses.Med Care. 2010;48:923-933.
2. Koshman SL,Charrois TL,Simpson SH,McAlister FA,Tsuyuki RT.Pharmacist care of patients with heart failure: a systematic review of randomized trials.Arch Intern Med. 2008;168:687-694.
3. Santschi V,Chiolero A,Burnand B,Colosimo AL,Paradis G.Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.Arch Intern Med. 2011;171:1441-1453.
4. Benavides S,Rodriguez JC,Maniscalco-Feichtl M.Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present.Ann Pharmacother. 2009;43:85-97.
5. Saberi P,Dong BJ,Johnson MO,Greenblatt RM,Cocohoba JM.The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.Patient Prefer Adherence. 2012;6:297-322.
6. Salgado TM,Moles R,Benrimoj SI,Fernandez-Llimos F.Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review.Nephrol Dial Transplant. 2012;27:276-292.
7. Stemer G,Lemmens-Gruber R.Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.BMC Nephrol. 2011;12:35.
8. Fixsen DL,Naoom SF,Blase KA,Friedman RM,Wallace FImplementation Research: A Synthesis of the Literature. Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network; 2005:.
9. Rabin BA,Brownson RC,Haire-Joshu D,Kreuter MW,Weaver NL.A glossary for dissemination and implementation research in health.J Public Health Manag Pract. 2008;14:117-123.
10. McBride D,Bruggenjurgen B,Roll S,Willich SN.Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice.J Thromb Thrombolysis. 2007;24:65-72.
11. Korenstein D,Falk R,Howell EA,Bishop T,Keyhani S.Overuse of health care services in the United States: an understudied problem.Arch Intern Med. 2012;172:171-178.
12. Melchiors AC,Correr CJ,Venson R,Pontarolo R.An analysis of quality of systematic reviews on pharmacist health interventions.Int J Clin Pharm. 2012;34:32-42.
13. Morgado MP,Morgado SR,Mendes LC,Pereira LJ,Castelo-Branco M.Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis.Am J Health Syst Pharm. 2011;68:241-253.
14. Charrois TL,Durec T,Tsuyuki RT.Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results.Ann Pharmacother. 2009;43:118-122.
15. Kennie NR,Schuster BG,Einarson TR.Critical analysis of the pharmaceutical care research literature.Ann Pharmacother. 1998;32:17-26.
16. Correr CJ,Melchiors AC,Souza TT,Rotta I,Salgado TM,Fernandez-Llimos F.A tool to characterize the components of pharmacist interventions in clinical pharmacy services: The DEPICT Project.Ann Pharmacother. 2013;47:946-952.
17. US National Library of Medicine. Search strategy used to create the systematic reviews subset on PubMed. http://www.nlm.nih.gov/bsd/pubmed_subsets/sysreviews_strategy.html. Accessed August 10, 2012.
18. Moher D,Liberati A,Tetzlaff J,Altman DG.Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.Ann Intern Med. 2009;151:264 W64-269.
19. Gallagher H,de Lusignan S,Harris K,Cates C.Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review.Br J Gen Pract. 2010;60:e258-65.
20. Idier L,Untas A,Koleck M,Chauveau P,Rascle N.Assessment and effects of Therapeutic Patient Education for patients in hemodialysis: a systematic review.Int J Nurs Stud. 2011;48:1570-1586.
21. Manley HJ,Cannella CA,Bailie GR,St Peter WL.Medication-related problems in ambulatory hemodialysis patients: a pooled analysis.Am J Kidney Dis. 2005;46:669-680.
22. Landis JR,Koch GG.The measurement of observer agreement for categorical data.Biometrics. 1977;33:159-174.
23. Thomas SG,Diethelm AG,Keith TD,Simmons SM.Evaluating the quality of patient education in a self-medication teaching program.Hosp Formul. 1983;18:871 877 881-874 878 882.
24. Golightly LK,O'Fallon CL,Moran WD,Sorocki AH.Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels.Hosp Pharm. 1993;28:725 730-727 732.
25. Soler Company E,Faus Soler MT,Olivas Ferrandis JL,Cuenca Soria A,Sarrio Quiles L.Intervention of the service of hospital pharmacy for the rational use of erythropoietin: clinical and economic assessment of its dispensing and administration to hemodialyzed patients.Farm Hosp. 1996;20:381-386.
26. Pharmacist-run program optimally manages secondary hyperparathyroidism.Hosp Formul. 1998;33:1217-1218.
27. Chisholm MA,Vollenweider LJ,Mulloy LL,Wynn JJ,Wade WE,DiPiro JT.Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.Clin Transplant. 2000;14:304-307.
28. Quercia RA,Abrahams R,White CM,D'Avella J,Campbell M.Cost avoidance and clinical benefits derived from a pharmacy-managed anemia program.Hosp Pharm. 2001;36:169-175.
29. To LL,Stoner CP,Stolley SN,Buenviaje JD,Ziegler TW.Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.Am J Health Syst Pharm. 2001;58:2061-2065.
30. Viola RA,Abbott KC,Welch PG,McMillan RJ,Sheikh AM,Yuan CM.A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients.BMC Nephrol. 2002;3:9.
31. Kimura T,Arai M,Masuda H,Kawabata A.Impact of a pharmacist-implemented anemia management in outpatients with end-stage renal disease in Japan.Biol Pharm Bull. 2004;27:1831-1833.
32. Salcedo J,Agudelo N,Baena MI.Pharmacotherapy follow-up to transplanted patients during hospitalization in Foundation Clinic Valle del Lili (Cali-Colombia) [in Spanish].Seguim Farmacoter. 2004;2:12-18.
33. Leung WY,So WY,Tong PC,Chan NN,Chan JC.Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.Am J Med. 2005;118:1414.
34. Walton T,Holloway KP,Knauss MD.Pharmacist-managed anemia program in an outpatient hemodialysis population.Hosp Pharm. 2005;40:1051-1056.
35. Allenet B,Chen C,Romanet T,Vialtel P,Calop J.Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.Pharm World Sci. 2007;29:7-11.
36. Ledger S,Choma G.Medication reconciliation in hemodialysis patients.CANNT J. 2008;18:41-43.
37. Yokum D,Glass G,Cheung CF,Cunningham J,Fan S,Madden AM.Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients.J Ren Nutr. 2008;18:521-529.
38. Hassan Y,Al-Ramahi RJ,Aziz NA,Ghazali R.Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.Ann Pharmacother. 2009;43:1598-1605.
39. Tang I,Vrahnos D,Hatoum H,Lau A.Effectiveness of clinical pharmacist interventions in a hemodialysis unit.Clin Ther. 1993;15:459 432-464.
40. Kaplan B,Shimp LA,Mason NA,Ascione FJ.Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program.Ann Pharmacother. 1994;28:320-324.
41. Grabe DW,Low CL,Bailie GR,Eisele G.Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.Clin Nephrol. 1997;47:117-121.
42. Possidente CJ,Bailie GR,Hood VL.Disruptions in drug therapy in long-term dialysis patients who require hospitalization.Am J Health Syst Pharm. 1999;56:1961-1964.
43. Chisholm MA,Vollenweider LJ,Mulloy LL,Jagadeesan M,Wade WE,DiPiro JT.Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team.Am J Health Syst Pharm. 2000;57:1994-1996.
44. Chisholm MA,Mulloy LL,Jagadeesan M,DiPiro JT.Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.Clin Transplant. 2001;15:330-336.
45. Chisholm MA,Mulloy LL,Jagadeesan M,Martin BC,DiPiro JT.Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients.Ethn Dis. 2002;12:392-397.
46. Manley HJ,Drayer DK,McClaran M,Bender W,Muther RS.Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center.Pharmacotherapy. 2003;23:231-239.
47. Manley HJ,Drayer DK,Muther RS.Medication-related problem type and appearance rate in ambulatory hemodialysis patients.BMC Nephrol. 2003;4:10.
48. Manley HJ,McClaran ML,Overbay DK,et al.Factors associated with medication-related problems in ambulatory hemodialysis patients.Am J Kidney Dis. 2003;41:386-393.
49. Mirkov S,Ball P.Design and pilot of a medication review clinic in a dialysis centre.J Pharm Pract. 2003;33:199-203.
50. Patel HR,Pruchnicki MC,Hall LE.Assessment for chronic kidney disease service in high-risk patients at community health clinics.Ann Pharmacother. 2005;39:22-27.
51. Bucaloiu ID,Akers G,Bermudez MC,et al.Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits.Manag Care Interface. 2007;20:26-30.
52. Chisholm MA,Spivey CA,Mulloy LL.Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients.Am J Health Syst Pharm. 2007;64:1506-1512.
53. Joy MS,Candiani C,Vaillancourt BA,Chin H,Hogan SL,Falk RJ.Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.Pharmacotherapy. 2007;27:734-744.
54. Sathvik BS,Mangasuli S,Narahari MG,Gurudev KC,Parthasarathi G.Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge.Ind J Pharm Sci. 2007;69:232-239.
55. Wang HY,Chan AL,Chen MT,Liao CH,Tian YF.Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.Transplant Proc. 2008;40:2319-2323.
56. Mirkov S.Implementation of a pharmacist medication review clinic for haemodialysis patients.N Z Med J. 2009;122:25-37.
57. Pai AB,Boyd A,Chavez A,Manley HJ.Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study.Hemodial Int. 2009;13:72-79.
58. Pai AB,Boyd A,Depczynski J,Chavez IM,Khan N,Manley H.Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.Pharmacotherapy. 2009;29:1433-1440.
59. Thomas D,Joseph J,Francis B,Mohanta GP.Effect of patient counseling on quality of life of hemodialysis patients in India.Pharm Pract. 2009;7:181-184.
60. Erickson AL,Szumita PM,Cotugno MC.Implementation of clinical pharmacy services in a dialysis unit.Am J Health Syst Pharm. 2008;65:2011-2013.
61. Grabe DW,Bailie GR,Manley HJ,Yeaw BF.The early patient-orientated care program as an educational tool and service.Am J Pharm Educ. 1998;62:279-284.
62. Smith V,Devane D,Begley CM,Clarke M.Methodology in conducting a systematic review of systematic reviews of healthcare interventions.BMC Med Res Methodol. 2011;11:15.
63. Singhal PK,Raisch DW,Gupchup GV.The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research.Ann Pharmacother. 1999;33:1336-1355.
64. Nkansah N,Mostovetsky O,Yu C,et al.Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.Cochrane Database Syst Rev. 2010; (7):.
65. Castelino RL,Bajorek BV,Chen TF.Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.Ann Pharmacother. 2009;43:1096-1106.
66. Tully MP,Seston EM.Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice.Ann Pharmacother. 2000;34:1320-1331.
67. Saez-Benito L,Fernandez-Llimos F,Feletto E,Gastelurrutia MA,Martinez-Martinez F,Benrimoj SI.Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients.Age Ageing. 2013;42:442-449.
68. Recommended Practices for Online Supplemental Journal Article Materials. Baltimore, MD: National Information Standards Organization; 2013:.
69. Castelino RL,Bajorek BV,Chen TF.Are interventions recommended by pharmacists during Home Medicines Review evidence-based?.J Eval Clin Pract. 2011;17:104-110.
70. Petty DR,Zermansky A.Study shows wrong people, wrong skills, wrong tools.BMJ. 2007;334:1180.
71. Holland R,Lenaghan E,Harvey I,et al.Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial.BMJ. 2005;330:293.
72. Holland R,Desborough J,Goodyer L,Hall S,Wright D,Loke YK.Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis.Br J Clin Pharmacol. 2008;65:303-316.
73. Zermansky AG,Petty DR,Raynor DK,Freemantle N,Vail A,Lowe CJ.Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice.BMJ. 2001;323:1340-1343.
74. Basheti IA,Armour CL,Bosnic-Anticevich SZ,Reddel HK.Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique.Patient Educ Couns. 2008;72:26-33.